Molecular Characterization and Correlation with β-lactam Resistance of Streptococcus pneumonia Isolates in Hangzhou, China.
- Author:
Mei Fen CHU
1
;
Xiao Xiang LIU
2
;
Shao Ni ZHANG
3
,
4
;
Yan Ying HUANG
3
,
4
;
Peng DU
2
;
Li Fang WANG
2
;
Lei JI
2
;
Jie YAN
5
,
6
;
Ai Hua SUN
2
Author Information
- Publication Type:Journal Article
- MeSH: Anti-Bacterial Agents; pharmacology; China; epidemiology; Drug Resistance, Bacterial; Humans; Pneumococcal Infections; epidemiology; microbiology; Streptococcus pneumoniae; drug effects; genetics; beta-Lactams; pharmacology
- From: Biomedical and Environmental Sciences 2018;31(5):389-393
- CountryChina
- Language:English
- Abstract: Penicillin-binding proteins (PBPs) are the target of β-lactam antibiotics (the major treatment for Streptococcus pneumoniae infections), and mutations in PBPs are considered as a primary mechanism for the development of β-lactam resistance in S. pneumoniae. This study was conducted to investigate the mutations in the PBPs of clinical S. pneumoniae isolates in Hangzhou, China, in correlation with β-lactam resistance. Results showed that 19F was the predominant serotype (7/27) and 14 of the S. pneumoniae isolates were resistant to both penicillin G and cephalosporin. Genotyping results suggested that β-lactam-resistant isolates primarily exhibited single-site mutations in both the STMK and SRNVP motifs of pbp1a in combination with double-site mutations in the STMK motif of pbp2x, which might be the primary mechanisms underlying the β-lactam resistance of the isolates in this study.